Cargando…
Transarterial chemoembolization combined with sorafenib and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850867/ https://www.ncbi.nlm.nih.gov/pubmed/34507316 http://dx.doi.org/10.1097/CM9.0000000000001537 |
_version_ | 1784652696945426432 |
---|---|
author | Huang, Jingjun Cai, Mingyue Huang, Wensou Guo, Yongjian Zhou, Jingwen Liang, Licong Lin, Liteng Zhou, Zhimei Lian, Hui He, Mingji Zhu, Kangshun |
author_facet | Huang, Jingjun Cai, Mingyue Huang, Wensou Guo, Yongjian Zhou, Jingwen Liang, Licong Lin, Liteng Zhou, Zhimei Lian, Hui He, Mingji Zhu, Kangshun |
author_sort | Huang, Jingjun |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8850867 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-88508672022-02-18 Transarterial chemoembolization combined with sorafenib and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study Huang, Jingjun Cai, Mingyue Huang, Wensou Guo, Yongjian Zhou, Jingwen Liang, Licong Lin, Liteng Zhou, Zhimei Lian, Hui He, Mingji Zhu, Kangshun Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2022-01-05 2021-09-09 /pmc/articles/PMC8850867/ /pubmed/34507316 http://dx.doi.org/10.1097/CM9.0000000000001537 Text en Copyright © 2021 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
spellingShingle | Correspondence Huang, Jingjun Cai, Mingyue Huang, Wensou Guo, Yongjian Zhou, Jingwen Liang, Licong Lin, Liteng Zhou, Zhimei Lian, Hui He, Mingji Zhu, Kangshun Transarterial chemoembolization combined with sorafenib and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study |
title | Transarterial chemoembolization combined with sorafenib and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study |
title_full | Transarterial chemoembolization combined with sorafenib and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study |
title_fullStr | Transarterial chemoembolization combined with sorafenib and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study |
title_full_unstemmed | Transarterial chemoembolization combined with sorafenib and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study |
title_short | Transarterial chemoembolization combined with sorafenib and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study |
title_sort | transarterial chemoembolization combined with sorafenib and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850867/ https://www.ncbi.nlm.nih.gov/pubmed/34507316 http://dx.doi.org/10.1097/CM9.0000000000001537 |
work_keys_str_mv | AT huangjingjun transarterialchemoembolizationcombinedwithsorafenibandiodine125seedbrachytherapyforhepatocellularcarcinomawithportalveintumorthrombusaretrospectivecontrolledstudy AT caimingyue transarterialchemoembolizationcombinedwithsorafenibandiodine125seedbrachytherapyforhepatocellularcarcinomawithportalveintumorthrombusaretrospectivecontrolledstudy AT huangwensou transarterialchemoembolizationcombinedwithsorafenibandiodine125seedbrachytherapyforhepatocellularcarcinomawithportalveintumorthrombusaretrospectivecontrolledstudy AT guoyongjian transarterialchemoembolizationcombinedwithsorafenibandiodine125seedbrachytherapyforhepatocellularcarcinomawithportalveintumorthrombusaretrospectivecontrolledstudy AT zhoujingwen transarterialchemoembolizationcombinedwithsorafenibandiodine125seedbrachytherapyforhepatocellularcarcinomawithportalveintumorthrombusaretrospectivecontrolledstudy AT lianglicong transarterialchemoembolizationcombinedwithsorafenibandiodine125seedbrachytherapyforhepatocellularcarcinomawithportalveintumorthrombusaretrospectivecontrolledstudy AT linliteng transarterialchemoembolizationcombinedwithsorafenibandiodine125seedbrachytherapyforhepatocellularcarcinomawithportalveintumorthrombusaretrospectivecontrolledstudy AT zhouzhimei transarterialchemoembolizationcombinedwithsorafenibandiodine125seedbrachytherapyforhepatocellularcarcinomawithportalveintumorthrombusaretrospectivecontrolledstudy AT lianhui transarterialchemoembolizationcombinedwithsorafenibandiodine125seedbrachytherapyforhepatocellularcarcinomawithportalveintumorthrombusaretrospectivecontrolledstudy AT hemingji transarterialchemoembolizationcombinedwithsorafenibandiodine125seedbrachytherapyforhepatocellularcarcinomawithportalveintumorthrombusaretrospectivecontrolledstudy AT zhukangshun transarterialchemoembolizationcombinedwithsorafenibandiodine125seedbrachytherapyforhepatocellularcarcinomawithportalveintumorthrombusaretrospectivecontrolledstudy |